Visualitza per autor "Derfuss, Tobias"
Ara mostrant els elements 1-3 d 3
-
Early and unrestricted access to high-efficacy disease-modifying therapies: a consensus to optimize benefits for people living with multiple sclerosis
Filippi, Massimo; Danesi, Romano; Derfuss, Tobias; Duddy, Martin; Gallo, Paolo; Tintore Subirana, Mar; Gold, Ralf (Springer, 2022-03) -
Early Reduction of MRI Activity During 6 Months of Treatment With Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis
De Stefano, Nicola; Montalban Gairín, Xavier; Achiron, Anat; Derfuss, Tobias; Chan, Andrew; Barkhof, Frederik (Lippincott Williams & Wilkins, 2022-07) -
Specific Patterns of Immune Cell Dynamics May Explain the Early Onset and Prolonged Efficacy of Cladribine Tablets: A MAGNIFY-MS Substudy
Wiendl, Heinz; Schmierer, Klaus; Hodgkinson, Suzanne; Derfuss, Tobias; Sellebjerg, Finn; Montalban Gairín, Xavier; Chan, Andrew (Lippincott Williams & Wilkins, 2023-01)